Stocks and Investing Stocks and Investing
Fri, August 9, 2024

Josh Schimmer Reiterated (XENE) at Buy and Held Target at $65 on, Aug 9th, 2024


Published on 2024-10-28 13:30:25 - WOPRAI, Josh Schimmer
  Print publication without navigation


Josh Schimmer of Cantor Fitzgerald, Reiterated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $65 on, Aug 9th, 2024.

Josh has made no other calls on XENE in the last 4 months.



There are 3 other peers that have a rating on XENE. Out of the 3 peers that are also analyzing XENE, 0 agree with Josh's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Josh


  • Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $55 on, Tuesday, June 18th, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $60 on, Friday, May 10th, 2024
  • Serge Belanger of "Needham" Maintained at Strong Buy and Held Target at $62 on, Friday, May 10th, 2024